{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:19:24Z","timestamp":1793506764908,"version":"4.5.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA272564"],"award-info":[{"award-number":["R01CA272564"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R21CA280814"],"award-info":[{"award-number":["R21CA280814"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA289701"],"award-info":[{"award-number":["R01CA289701"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02703-7","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:04:56Z","timestamp":1775545496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Suppression of mitochondrial energy production by a photosynthetic bacterial cupredoxin peptide inhibits tumor growth"],"prefix":"10.1038","volume":"11","author":[{"given":"Samer A.","family":"Naffouje","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1591-2611","authenticated-orcid":false,"given":"Duy Binh","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Rademacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Botti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Christov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8125-3824","authenticated-orcid":false,"given":"Weiguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc Hai Trieu","family":"Phong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cannistraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rita","family":"Bizzarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapas K.","family":"Das Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6594-3534","authenticated-orcid":false,"given":"Tohru","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"2703_CR1","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.molcel.2016.02.011","volume":"61","author":"W-X Zong","year":"2016","unstructured":"Zong, W.-X., Rabinowitz, J. D. & White, E. Mitochondria and cancer. Mol. cell 61, 667\u2013676 (2016).","journal-title":"Mol. cell"},{"key":"2703_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.mam.2009.12.003","volume":"31","author":"F Wang","year":"2010","unstructured":"Wang, F., Ogasawara, M. A. & Huang, P. Small mitochondria-targeting molecules as anticancer agents. Mol. Asp. Med. 31, 75\u201392 (2010).","journal-title":"Mol. Asp. Med."},{"key":"2703_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10549-019-05174-3","volume":"176","author":"S Speransky","year":"2019","unstructured":"Speransky, S. et al. A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer. Breast Cancer Res. Treat. 176, 271\u2013289 (2019).","journal-title":"Breast Cancer Res. Treat."},{"key":"2703_CR4","doi-asserted-by":"publisher","first-page":"66925","DOI":"10.18632\/oncotarget.19963","volume":"8","author":"F Sotgia","year":"2017","unstructured":"Sotgia, F. & Lisanti, M. P. Mitochondrial mRNA transcripts predict overall survival, tumor recurrence and progression in serous ovarian cancer: Companion diagnostics for cancer therapy. Oncotarget 8, 66925\u201366939 (2017).","journal-title":"Oncotarget"},{"key":"2703_CR5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/cdd.2017.169","volume":"25","author":"BJ Aubrey","year":"2018","unstructured":"Aubrey, B. J., Kelly, G. L., Janic, A., Herold, M. J. & Strasser, A. How does p53 induce apoptosis and how does this relate to p53-mediated tumor suppression? Cell Death Differ. 25, 104\u2013113 (2018).","journal-title":"Cell Death Differ."},{"key":"2703_CR6","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1158\/0008-5472.CAN-19-2948","volume":"80","author":"H-R Cha","year":"2020","unstructured":"Cha, H.-R., Lee, J. H. & Ponnazhagan, S. Revisiting immunotherapy: A focus on prostate cancer. Cancer Res. 80, 1615\u20131623 (2020).","journal-title":"Cancer Res."},{"key":"2703_CR7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ceb.2016.05.008","volume":"41","author":"JP McCutcheon","year":"2016","unstructured":"McCutcheon, J. P. From microbiology to cell biology: when an intracellular bacterium becomes part of its host cell. Curr. Opin. cell Biol. 41, 132\u2013136 (2016).","journal-title":"Curr. Opin. cell Biol."},{"key":"2703_CR8","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1091\/mbc.e16-07-0509","volume":"28","author":"MW Gray","year":"2017","unstructured":"Gray, M. W. Lynn Margulis and the endosymbiont hypothesis: 50 years later. Mol. Biol. Cell 28, 1285\u20131287 (2017).","journal-title":"Mol. Biol. Cell"},{"key":"2703_CR9","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1105\/tpc.18.00016","volume":"30","author":"R Zoschke","year":"2018","unstructured":"Zoschke, R. & Bock, R. Chloroplast translation: Structural and functional organization, operational control, and regulation. Plant cell 30, 745\u2013770 (2018).","journal-title":"Plant cell"},{"key":"2703_CR10","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.3390\/molecules25122857","volume":"25","author":"K Boguszewska","year":"2020","unstructured":"Boguszewska, K., Szewczuk, M., Kazmierczak-Baranska, J. & Karwowski, B. T. The similarities between human mitochondria and bacteria in the context of structure, genome, and base excision repair system. Molecules 25, 2857 (2020).","journal-title":"Molecules"},{"key":"2703_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.bbamcr.2012.05.029","volume":"1833","author":"C Carrie","year":"2013","unstructured":"Carrie, C. & Small, I. A reevaluation of dual-targeting of proteins to mitochondria and chloroplasts. Biochim. et. Biophys. Acta (BBA) - Mol. Cell Res. 1833, 253\u2013259 (2013).","journal-title":"Biochim. et. Biophys. Acta (BBA) - Mol. Cell Res."},{"key":"2703_CR12","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/pro.5560060402","volume":"6","author":"ME Murphy","year":"1997","unstructured":"Murphy, M. E., Lindley, P. F. & Adman, E. T. Structural comparison of cupredoxin domains: domain recycling to construct proteins with novel functions. Protein Sci. 6, 761\u2013770 (1997).","journal-title":"Protein Sci."},{"key":"2703_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/jmr.861","volume":"21","author":"FJ Stevens","year":"2008","unstructured":"Stevens, F. J. Homology versus analogy: possible evolutionary relationship of immunoglobulins, cupredoxins, and Cu,Zn-superoxide dismutase. J. Mol. Recognit.: JMR 21, 20\u201329 (2008).","journal-title":"J. Mol. Recognit.: JMR"},{"key":"2703_CR14","doi-asserted-by":"publisher","first-page":"7919","DOI":"10.1073\/pnas.0711316105","volume":"105","author":"MG Savelieff","year":"2008","unstructured":"Savelieff, M. G. et al. Experimental evidence for a link among cupredoxins: Red, blue, and purple copper transformations in nitrous oxide reductase. Proc. Natl. Acad. Sci. 105, 7919\u20137924 (2008).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"2703_CR15","doi-asserted-by":"publisher","first-page":"982","DOI":"10.3390\/genes11090982","volume":"11","author":"M Makarenko","year":"2020","unstructured":"Makarenko, M. et al. The investigation of perennial sunflower species (Helianthus L.) mitochondrial genomes. Genes (Basel) 11, 982 (2020).","journal-title":"Genes (Basel)"},{"key":"2703_CR16","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1083\/jcb.108.4.1397","volume":"108","author":"W Haehnel","year":"1989","unstructured":"Haehnel, W., Ratajczak, R. & Robenek, H. Lateral distribution and diffusion of plastocyanin in chloroplast thylakoids. J. Cell Biol. 108, 1397\u20131405 (1989).","journal-title":"J. Cell Biol."},{"key":"2703_CR17","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1110\/ps.9.8.1439","volume":"9","author":"F De Rienzo","year":"2000","unstructured":"De Rienzo, F., Gabdoulline, R. R., Menziani, M. C. & Wade, R. C. Blue copper proteins: a comparative analysis of their molecular interaction properties. Protein Sci.: a Publ. Protein Soc. 9, 1439\u20131454 (2000).","journal-title":"Protein Sci.: a Publ. Protein Soc."},{"key":"2703_CR18","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1006\/jmbi.2001.5253","volume":"315","author":"LM Murphy","year":"2002","unstructured":"Murphy, L. M., Dodd, F. E., Yousafzai, F. K., Eady, R. R. & Hasnain, S. S. Electron donation between copper containing nitrite reductases and cupredoxins: the nature of protein\u2012protein interaction in complex formation. J. Mol. Biol. 315, 859\u2013871 (2002).","journal-title":"J. Mol. Biol."},{"key":"2703_CR19","doi-asserted-by":"publisher","first-page":"14098","DOI":"10.1073\/pnas.222539699","volume":"99","author":"T Yamada","year":"2002","unstructured":"Yamada, T. et al. Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer. Proc. Natl. Acad. Sci. USA 99, 14098\u201314103 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2703_CR20","doi-asserted-by":"publisher","first-page":"7054","DOI":"10.1128\/IAI.70.12.7054-7062.2002","volume":"70","author":"T Yamada","year":"2002","unstructured":"Yamada, T. et al. The bacterial redox protein azurin induces apoptosis in J774 macrophages through complex formation and stabilization of the tumor suppressor protein p53. Infect. Immun. 70, 7054\u20137062 (2002).","journal-title":"Infect. Immun."},{"key":"2703_CR21","doi-asserted-by":"crossref","unstructured":"Pseudomonas gives cancer cells the blues. Science\u2019s STKE 2002, tw416-tw416 (2002).","DOI":"10.1126\/scisignal.1582002tw416"},{"key":"2703_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00280-010-1518-3","volume":"68","author":"L Jia","year":"2011","unstructured":"Jia, L. et al. Preclinical pharmacokinetics, metabolism, and toxicity of azurin-p28 (NSC745104) a peptide inhibitor of p53 ubiquitination. Cancer Chemother. Pharmacol. 68, 513\u2013524 (2011).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"2703_CR23","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1021\/mp400221r","volume":"10","author":"T Yamada","year":"2013","unstructured":"Yamada, T., Das Gupta, T. K. & Beattie, C. W. p28, an anionic cell-penetrating peptide, increases the activity of wild type and mutated p53 without altering its conformation. Mol. Pharm. 10, 3375\u20133383 (2013).","journal-title":"Mol. Pharm."},{"key":"2703_CR24","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1158\/1535-7163.MCT-09-0444","volume":"8","author":"T Yamada","year":"2009","unstructured":"Yamada, T. et al. A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells. Mol. Cancer Ther. 8, 2947\u20132958 (2009).","journal-title":"Mol. Cancer Ther."},{"key":"2703_CR25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1021\/mp500495u","volume":"12","author":"T Yamada","year":"2015","unstructured":"Yamada, T., Signorelli, S., Cannistraro, S., Beattie, C. W. & Bizzarri, A. R. Chirality switching within an anionic cell-penetrating peptide inhibits translocation without affecting preferential entry. Mol. Pharm. 12, 140\u2013149 (2015).","journal-title":"Mol. Pharm."},{"key":"2703_CR26","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1158\/0008-5472.CAN-15-2355","volume":"76","author":"T Yamada","year":"2016","unstructured":"Yamada, T., Das Gupta, T. K. & Beattie, C. W. p28-mediated activation of p53 in G2\u2013M phase of the cell cycle enhances the efficacy of DNA damaging and antimitotic chemotherapy. Cancer Res. 76, 2354\u20132365 (2016).","journal-title":"Cancer Res."},{"key":"2703_CR27","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/bjc.2013.74","volume":"108","author":"MA Warso","year":"2013","unstructured":"Warso, M. A. et al. A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumors. Br. J. Cancer 108, 1061\u20131070 (2013).","journal-title":"Br. J. Cancer"},{"issue":"9","key":"2703_CR28","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1093\/neuonc\/now047","volume":"18","author":"R Lulla","year":"2016","unstructured":"Lulla, R. et al. Phase 1 trial of p28 (NSC745104), a non-HDM2 mediated peptide inhibitor of p53 ubiquitination in children with recurrent or progressive CNS tumors: A final report from the pediatric brain tumor consortium. Neuro Oncol. 18(9), 1319\u20131325 (2016).","journal-title":"Neuro Oncol."},{"key":"2703_CR29","doi-asserted-by":"crossref","unstructured":"Razzak, M. One step closer to drugging p53. Nat. Rev. Clin. Oncol. 10, 246 (2013).","DOI":"10.1038\/nrclinonc.2013.43"},{"key":"2703_CR30","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1104\/pp.110.161687","volume":"154","author":"RE Blankenship","year":"2010","unstructured":"Blankenship, R. E. Early evolution of photosynthesis. Plant Physiol. 154, 434\u2013438 (2010).","journal-title":"Plant Physiol."},{"key":"2703_CR31","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jiac.2017.04.001","volume":"23","author":"SL Mitchell","year":"2017","unstructured":"Mitchell, S. L., Blumberg, E. A. & Edelstein, P. H. Bacteremia caused by the photosynthetic environmental bacterium Rhodopseudomonas. J. Infect. Chemother. 23, 720\u2013723 (2017).","journal-title":"J. Infect. Chemother."},{"key":"2703_CR32","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.01102","volume":"2","author":"SC Di Rienzi","year":"2013","unstructured":"Di Rienzi, S. C. et al. The human gut and groundwater harbor nonphotosynthetic bacteria belonging to a new candidate phylum sibling to Cyanobacteria. Elife 2, e01102 (2013).","journal-title":"Elife"},{"key":"2703_CR33","doi-asserted-by":"publisher","first-page":"6531","DOI":"10.1016\/S0021-9258(19)50460-4","volume":"267","author":"JD McManus","year":"1992","unstructured":"McManus, J. D. et al. Isolation, characterization, and amino acid sequences of auracyanins, blue copper proteins from the green photosynthetic bacterium Chloroflexus aurantiacus. J. Biol. Chem. 267, 6531\u20136540 (1992).","journal-title":"J. Biol. Chem."},{"key":"2703_CR34","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1110\/ps.8.5.947","volume":"8","author":"G Van Driessche","year":"1999","unstructured":"Van Driessche, G. et al. Auracyanin A from the thermophilic green gliding photosynthetic bacterium Chloroflexus aurantiacus represents an unusual class of small blue copper proteins. Protein Sci.: a Publ. Protein Soc. 8, 947\u2013957 (1999).","journal-title":"Protein Sci.: a Publ. Protein Soc."},{"key":"2703_CR35","doi-asserted-by":"publisher","first-page":"eabc4552","DOI":"10.1126\/science.abc4552","volume":"371","author":"GD Sepich-Poore","year":"2021","unstructured":"Sepich-Poore, G. D. et al. The microbiome and human cancer. Science 371, eabc4552 (2021).","journal-title":"Science"},{"key":"2703_CR36","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.ccell.2021.08.006","volume":"39","author":"N Cullin","year":"2021","unstructured":"Cullin, N., Azevedo Antunes, C., Straussman, R., Stein-Thoeringer, C. K. & Elinav, E. Microbiome and cancer. Cancer Cell 39, 1317\u20131341 (2021).","journal-title":"Cancer Cell"},{"key":"2703_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s42003-022-04395-5","volume":"6","author":"JK Choi","year":"2023","unstructured":"Choi, J. K. et al. Cross-talk between cancer and Pseudomonas aeruginosa mediates tumor suppression. Commun. Biol. 6, 16 (2023).","journal-title":"Commun. Biol."},{"key":"2703_CR38","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman, D. et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science 368, 973\u2013980 (2020).","journal-title":"Science"},{"key":"2703_CR39","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s00203-024-03985-7","volume":"206","author":"K Yeo","year":"2024","unstructured":"Yeo, K. et al. A comparison between full-length 16S rRNA Oxford nanopore sequencing and Illumina V3-V4 16S rRNA sequencing in head and neck cancer tissues. Arch. Microbiol 206, 248 (2024).","journal-title":"Arch. Microbiol"},{"key":"2703_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-023-01677-6","volume":"25","author":"R German","year":"2023","unstructured":"German, R. et al. Exploring breast tissue microbial composition and the association with breast cancer risk factors. Breast Cancer Res. 25, 82 (2023).","journal-title":"Breast Cancer Res."},{"key":"2703_CR41","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1111\/j.1462-5822.2005.00567.x","volume":"7","author":"T Yamada","year":"2005","unstructured":"Yamada, T. et al. Internalization of bacterial redox protein azurin in mammalian cells: Entry domain and specificity. Cell. Microbiol. 7, 1418\u20131431 (2005).","journal-title":"Cell. Microbiol."},{"key":"2703_CR42","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1158\/0008-5472.CAN-08-2932","volume":"69","author":"BN Taylor","year":"2009","unstructured":"Taylor, B. N. et al. Noncationic peptides obtained from azurin preferentially enter cancer cells. Cancer Res. 69, 537\u2013546 (2009).","journal-title":"Cancer Res."},{"key":"2703_CR43","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1158\/1538-7445.AM2017-2311","volume":"77","author":"SA Naffouje","year":"2017","unstructured":"Naffouje, S. A., Yamada, T. & Gupta, T. K. D. A peptide derived from a photosynthetic cupredoxin protein, auracyanin, induces a p53-independent apoptosis in cancer cells. Cancer Res. 77, 2311\u20132311 (2017).","journal-title":"Cancer Res."},{"key":"2703_CR44","doi-asserted-by":"publisher","first-page":"4599","DOI":"10.1158\/0008-5472.CAN-12-4414","volume":"73","author":"N Mitsiades","year":"2013","unstructured":"Mitsiades, N. A road map to comprehensive androgen receptor axis targeting for castration-resistant prostate cancer. Cancer Res. 73, 4599\u20134605 (2013).","journal-title":"Cancer Res."},{"key":"2703_CR45","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/j.1742-1241.2011.02799.x","volume":"65","author":"M Kirby","year":"2011","unstructured":"Kirby, M., Hirst, C. & Crawford, E. D. Characterizing the castration-resistant prostate cancer population: A systematic review. Int. J. Clin. Pract. 65, 1180\u20131192 (2011).","journal-title":"Int. J. Clin. Pract."},{"key":"2703_CR46","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1001\/jamaoncol.2019.4097","volume":"6","author":"S Terrisse","year":"2020","unstructured":"Terrisse, S. et al. Overall survival in men with bone metastases from castration-resistant prostate cancer treated with bone-targeting radioisotopes: A meta-analysis of individual patient data from randomized clinical trials. JAMA Oncol. 6, 206\u2013216 (2020).","journal-title":"JAMA Oncol."},{"key":"2703_CR47","first-page":"485","volume":"75","author":"TB Kratzer","year":"2025","unstructured":"Kratzer, T. B. et al. Prostate cancer statistics, 2025. CA: A Cancer J. Clin. 75, 485\u2013497 (2025).","journal-title":"CA: A Cancer J. Clin."},{"key":"2703_CR48","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1038\/s41467-020-17670-y","volume":"11","author":"C Robert","year":"2020","unstructured":"Robert, C. A decade of immune-checkpoint inhibitors in cancer therapy. Nat. Commun. 11, 3801\u20133801 (2020).","journal-title":"Nat. Commun."},{"key":"2703_CR49","doi-asserted-by":"publisher","first-page":"11636","DOI":"10.1073\/pnas.1934692100","volume":"100","author":"Z Zhang","year":"2003","unstructured":"Zhang, Z., Li, M., Wang, H., Agrawal, S. & Zhang, R. Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy. Proc. Natl. Acad. Sci. USA 100, 11636\u201311641 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2703_CR50","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5045\/br.2014.49.1.49","volume":"49","author":"R Shiri","year":"2014","unstructured":"Shiri, R., Yari, F., Ahmadinejad, M., Vaeli, S. & Tabatabaei, M. R. The caspase-3 inhibitor (peptide Z-DEVD-FMK) affects the survival and function of platelets in platelet concentrate during storage. Blood Res. 49, 49\u201353 (2014).","journal-title":"Blood Res."},{"key":"2703_CR51","doi-asserted-by":"publisher","first-page":"117365","DOI":"10.1016\/j.biopha.2024.117365","volume":"179","author":"M El Gaafary","year":"2024","unstructured":"El Gaafary, M. et al. Prenylated xanthones from mangosteen (Garcinia mangostana) target oxidative mitochondrial respiration in cancer cells. Biomed. Pharmacother. 179, 117365 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"2703_CR52","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/351453a0","volume":"351","author":"AJ Levine","year":"1991","unstructured":"Levine, A. J., Momand, J. & Finlay, C. A. The p53 tumor suppressor gene. Nature 351, 453\u2013456 (1991).","journal-title":"Nature"},{"key":"2703_CR53","first-page":"349","volume":"66","author":"D Chendil","year":"2006","unstructured":"Chendil, D., Srinivasan, S. & Ranga, R. Apoptosis regulation by androgen receptor (AR) in prostate cancer biology. Cancer Res. 66, 349\u2013349 (2006).","journal-title":"Cancer Res."},{"key":"2703_CR54","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1158\/0008-5472.CAN-03-2428","volume":"64","author":"X Wang","year":"2004","unstructured":"Wang, X., Deng, H., Basu, I. & Zhu, L. Induction of androgen receptor-dependent apoptosis in prostate cancer cells by the retinoblastoma protein. Cancer Res. 64, 1377\u20131385 (2004).","journal-title":"Cancer Res."},{"key":"2703_CR55","doi-asserted-by":"publisher","first-page":"113660","DOI":"10.1016\/j.jconrel.2025.113660","volume":"382","author":"DB Tran","year":"2025","unstructured":"Tran, D. B. et al. Intracellular redistribution of cell-penetrating peptide p28: A mechanism for enhanced anticancer activity. J. Controlled Release 382, 113660 (2025).","journal-title":"J. Controlled Release"},{"key":"2703_CR56","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1021\/nn301282m","volume":"6","author":"K Huang","year":"2012","unstructured":"Huang, K. et al. Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. ACS Nano 6, 4483\u20134493 (2012).","journal-title":"ACS Nano"},{"key":"2703_CR57","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nature12985","volume":"505","author":"JR Friedman","year":"2014","unstructured":"Friedman, J. R. & Nunnari, J. Mitochondrial form and function. Nature 505, 335\u2013343 (2014).","journal-title":"Nature"},{"key":"2703_CR58","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000227831","volume":"125","author":"J Wang","year":"2009","unstructured":"Wang, J. et al. Involvement of the mitochondrial pathway in p53-independent apoptosis induced by p28GANK knockdown in Hep3B cells. Cytogenetic genome Res. 125, 87\u201397 (2009).","journal-title":"Cytogenetic genome Res."},{"key":"2703_CR59","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.bbabio.2008.10.005","volume":"1787","author":"AV Vaseva","year":"2009","unstructured":"Vaseva, A. V. & Moll, U. M. The mitochondrial p53 pathway. Biochim. et. Biophys. Acta 1787, 414\u2013420 (2009).","journal-title":"Biochim. et. Biophys. Acta"},{"key":"2703_CR60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bbabio.2004.01.008","volume":"1656","author":"PM Herst","year":"2004","unstructured":"Herst, P. M., Tan, A. S., Scarlett, D.-J. G. & Berridge, M. V. Cell surface oxygen consumption by mitochondrial gene knockout cells. Biochim. et. Biophys. Acta (BBA) - Bioenerg. 1656, 79\u201387 (2004).","journal-title":"Biochim. et. Biophys. Acta (BBA) - Bioenerg."},{"key":"2703_CR61","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.eururo.2015.06.039","volume":"68","author":"BA Gartrell","year":"2015","unstructured":"Gartrell, B. A. et al. Metastatic prostate cancer and the bone: Significance and therapeutic options. Eur. Urol. 68, 850\u2013858 (2015).","journal-title":"Eur. Urol."},{"key":"2703_CR62","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/358015a0","volume":"358","author":"DP Lane","year":"1992","unstructured":"Lane, D. P. Cancer. p53, guardian of the genome. Nature 358, 15\u201316 (1992).","journal-title":"Nature"},{"key":"2703_CR63","first-page":"3429","volume":"60","author":"AY Liu","year":"2000","unstructured":"Liu, A. Y. Differential expression of cell surface molecules in prostate cancer cells. Cancer Res. 60, 3429\u20133434 (2000).","journal-title":"Cancer Res."},{"key":"2703_CR64","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrc3064","volume":"11","author":"WR Wilson","year":"2011","unstructured":"Wilson, W. R. & Hay, M. P. Targeting hypoxia in cancer therapy. Nat. Rev. Cancer 11, 393\u2013410 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"2703_CR65","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13046-020-01724-6","volume":"39","author":"F Mudassar","year":"2020","unstructured":"Mudassar, F., Shen, H., O\u2019Neill, G. & Hau, E. Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas. J. Exp. Clin. Cancer Res. 39, 208 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2703_CR66","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.radmp.2020.01.006","volume":"1","author":"R Huang","year":"2020","unstructured":"Huang, R. & Zhou, P.-K. HIF-1 signaling: A key orchestrator of cancer radioresistance. Radiat. Med. Prot. 1, 7\u201314 (2020).","journal-title":"Radiat. Med. Prot."},{"key":"2703_CR67","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00280-016-3007-9","volume":"77","author":"F Zhao","year":"2016","unstructured":"Zhao, F., Ming, J., Zhou, Y. & Fan, L. Inhibition of Glut1 by WZB117 sensitizes radioresistant breast cancer cells to irradiation. Cancer Chemother. Pharmacol. 77, 963\u2013972 (2016).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"2703_CR68","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/cancers10050135","volume":"10","author":"E Toufektchan","year":"2018","unstructured":"Toufektchan, E. & Toledo, F. The guardian of the genome revisited: p53 downregulates genes required for telomere maintenance, DNA repair, and centromere structure. Cancers (Basel) 10, 135 (2018).","journal-title":"Cancers (Basel)"},{"key":"2703_CR69","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","volume":"25","author":"PAJ Muller","year":"2014","unstructured":"Muller, P. A. J. & Vousden, K. H. Mutant p53 in cancer: new functions and therapeutic opportunities. Cancer cell 25, 304\u2013317 (2014).","journal-title":"Cancer cell"},{"key":"2703_CR70","doi-asserted-by":"publisher","first-page":"13303","DOI":"10.1073\/pnas.1835733100","volume":"100","author":"N Issaeva","year":"2003","unstructured":"Issaeva, N. et al. Rescue of mutants of the tumor suppressor p53 in cancer cells by a designed peptide. Proc. Natl. Acad. Sci. 100, 13303\u201313307 (2003).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"2703_CR71","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/pros.21383","volume":"71","author":"S Tai","year":"2011","unstructured":"Tai, S. et al. PC3 is a cell line characteristic of prostatic small cell carcinoma. Prostate 71, 1668\u20131679 (2011).","journal-title":"Prostate"},{"key":"2703_CR72","doi-asserted-by":"publisher","first-page":"320","DOI":"10.5858\/arpa.2019-0434-RA","volume":"144","author":"J Hu","year":"2019","unstructured":"Hu, J., Han, B. & Huang, J. Morphologic spectrum of neuroendocrine tumors of the prostate: An updated review. Arch. Pathol. Lab. Med. 144, 320\u2013325 (2019).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"2703_CR73","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1200\/JCO.2019.37.7_suppl.224","volume":"37","author":"A Ferguson","year":"2019","unstructured":"Ferguson, A. et al. Immunogenomic landscape of neuroendocrine prostate cancer (NEPC). J. Clin. Oncol. 37, 224\u2013224 (2019).","journal-title":"J. Clin. Oncol."},{"key":"2703_CR74","unstructured":"Cancer Facts & Figures 2020. American Cancer Society 1\u201370 (2020)."},{"key":"2703_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41632-0","volume":"9","author":"N Gupta","year":"2019","unstructured":"Gupta, N., Gupta, P. & Srivastava, S. K. Penfluridol overcomes paclitaxel resistance in metastatic breast cancer. Sci. Rep. 9, 5066 (2019).","journal-title":"Sci. Rep."},{"key":"2703_CR76","doi-asserted-by":"crossref","unstructured":"Williams, C. & Bryant, A. Short versus long duration infusions of paclitaxel for any advanced adenocarcinoma. Cochrane Database Syst. Rev. CD003911-CD003911 (2011).","DOI":"10.1002\/14651858.CD003911.pub2"},{"key":"2703_CR77","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1074\/jbc.M209548200","volume":"278","author":"JP Richard","year":"2003","unstructured":"Richard, J. P. et al. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278, 585\u2013590 (2003).","journal-title":"J. Biol. Chem."},{"key":"2703_CR78","doi-asserted-by":"publisher","first-page":"9038","DOI":"10.3390\/ijms23169038","volume":"23","author":"M Hao","year":"2022","unstructured":"Hao, M., Zhang, L. & Chen, P. Membrane internalization mechanisms and design strategies of Arginine-rich Cell-Penetrating Peptides. Int. J. Mol. Sci 23, 9038 (2022).","journal-title":"Int. J. Mol. Sci"},{"key":"2703_CR79","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-1-0716-1752-6_10","volume":"2383","author":"F Madani","year":"2022","unstructured":"Madani, F. & Gr\u00e4slund, A. Membrane molecular interactions and induced structures of CPPs. Methods Mol. Biol. (Clifton, N. J.) 2383, 153\u2013165 (2022).","journal-title":"Methods Mol. Biol. (Clifton, N. J.)"},{"key":"2703_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-86130-8","volume":"15","author":"D Yang","year":"2025","unstructured":"Yang, D., Liu, B. & Sha, H. Advances and prospects of cell-penetrating peptides in tumor immunotherapy. Sci. Rep. 15, 3392 (2025).","journal-title":"Sci. Rep."},{"key":"2703_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23071-6","volume":"12","author":"EL Giddings","year":"2021","unstructured":"Giddings, E. L. et al. Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance. Nat. Commun. 12, 2804 (2021).","journal-title":"Nat. Commun."},{"key":"2703_CR82","doi-asserted-by":"publisher","first-page":"740720","DOI":"10.3389\/fonc.2021.740720","volume":"11","author":"M Fiorillo","year":"2021","unstructured":"Fiorillo, M., \u00d3zsv\u00e1ri, B., Sotgia, F. & Lisanti, M. High ATP production fuels cancer drug resistance and metastasis: Implications for mitochondrial ATP depletion therapy. Front. Oncol. 11, 740720 (2021).","journal-title":"Front. Oncol."},{"key":"2703_CR83","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1038\/s41418-021-00788-x","volume":"28","author":"M Fiorillo","year":"2021","unstructured":"Fiorillo, M., Scatena, C., Naccarato, A. G., Sotgia, F. & Lisanti, M. P. Bedaquiline, an FDA-approved drug, inhibits mitochondrial ATP production and metastasis in vivo, by targeting the gamma subunit (ATP5F1C) of the ATP synthase. Cell Death Differ. 28, 2797\u20132817 (2021).","journal-title":"Cell Death Differ."},{"key":"2703_CR84","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2008.01.006","volume":"18","author":"V Gogvadze","year":"2008","unstructured":"Gogvadze, V., Orrenius, S. & Zhivotovsky, B. Mitochondria in cancer cells: what is so special about them? Trends cell Biol. 18, 165\u2013173 (2008).","journal-title":"Trends cell Biol."},{"key":"2703_CR85","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.mito.2004.07.027","volume":"4","author":"JS Modica-Napolitano","year":"2004","unstructured":"Modica-Napolitano, J. S. & Singh, K. K. Mitochondrial dysfunction in cancer. Mitochondrion 4, 755\u2013762 (2004).","journal-title":"Mitochondrion"},{"key":"2703_CR86","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrd3137","volume":"9","author":"S Fulda","year":"2010","unstructured":"Fulda, S., Galluzzi, L. & Kroemer, G. Targeting mitochondria for cancer therapy. Nat. Rev. Drug Discov. 9, 447\u2013464 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2703_CR87","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1347174","volume":"2018","author":"RG Feichtinger","year":"2018","unstructured":"Feichtinger, R. G. et al. Reduced levels of ATP synthase subunit ATP5F1A correlate with earlier-onset prostate cancer. Oxid. Med. Cell. Longev. 2018, 1347174 (2018).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"2703_CR88","doi-asserted-by":"publisher","first-page":"68095","DOI":"10.18632\/oncotarget.19677","volume":"8","author":"F Sotgia","year":"2017","unstructured":"Sotgia, F. & Lisanti, M. P. Mitochondrial markers predict survival and progression in non-small cell lung cancer (NSCLC) patients: Use as companion diagnostics. Oncotarget 8, 68095\u201368107 (2017).","journal-title":"Oncotarget"},{"key":"2703_CR89","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3892\/ijo.2017.3878","volume":"50","author":"W Li","year":"2017","unstructured":"Li, W. et al. Ectopic expression of the ATP synthase \u03b2 subunit on the membrane of PC-3 M cells supports its potential role in prostate cancer metastasis. Int. J. Oncol. 50, 1312\u20131320 (2017).","journal-title":"Int. J. Oncol."},{"key":"2703_CR90","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.omto.2021.08.015","volume":"23","author":"T Wang","year":"2021","unstructured":"Wang, T., Ma, F. & Qian, H. L. Defueling the cancer: ATP synthase as an emerging target in cancer therapy. Mol. Ther. Oncolytics 23, 82\u201395 (2021).","journal-title":"Mol. Ther. Oncolytics"},{"key":"2703_CR91","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/00008390-200202000-00005","volume":"12","author":"RR Mehta","year":"2002","unstructured":"Mehta, R. R. et al. In vitro transformation of human congenital naevus to malignant melanoma. Melanoma Res. 12, 27\u201333 (2002).","journal-title":"Melanoma Res."},{"key":"2703_CR92","first-page":"2457","volume":"14","author":"S Rauth","year":"1994","unstructured":"Rauth, S., Kichina, J., Green, A., Bratescu, L. & Das Gupta, T. K. Establishment of a human melanoma cell line lacking p53 expression and spontaneously metastasizing in nude mice. Anticancer Res 14, 2457\u20132463 (1994).","journal-title":"Anticancer Res"},{"key":"2703_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-33157-6","volume":"16","author":"S Mander","year":"2025","unstructured":"Mander, S. et al. Improvement of DCIS resection using intraoperative imaging with ICG-p28. Sci. Rep. 16, 3136 (2025).","journal-title":"Sci. Rep."},{"key":"2703_CR94","doi-asserted-by":"publisher","first-page":"950979","DOI":"10.3389\/fcell.2022.950979","volume":"10","author":"M Tourmente","year":"2022","unstructured":"Tourmente, M., Sansegundo, E., Rial, E. & Roldan, E. R. S. Capacitation promotes a shift in energy metabolism in murine sperm. Front. Cell Dev. Biol. 10, 950979 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"2703_CR95","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1038\/bjc.2013.266","volume":"108","author":"T Yamada","year":"2013","unstructured":"Yamada, T. et al. p28, a first in class peptide inhibitor of cop1 binding to p53. Br. J. Cancer 108, 2495\u20132504 (2013).","journal-title":"Br. J. Cancer"},{"key":"2703_CR96","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1158\/1078-0432.1253.11.3","volume":"11","author":"N El Hilali","year":"2005","unstructured":"El Hilali, N., Rubio, N. & Blanco, J. Different effect of paclitaxel on primary tumor mass, tumor cell contents, and metastases for four experimental human prostate tumors expressing luciferase. Clin. Cancer Res. 11, 1253\u20131258 (2005).","journal-title":"Clin. Cancer Res."},{"key":"2703_CR97","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1038\/sj.onc.1207376","volume":"23","author":"V Punj","year":"2004","unstructured":"Punj, V. et al. Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer. Oncogene 23, 2367\u20132378 (2004).","journal-title":"Oncogene"},{"key":"2703_CR98","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.4231","volume":"11","author":"B Zhang","year":"2021","unstructured":"Zhang, B., Li, X., Qian, W. P., Wu, D. & Dong, J. T. Measurement of bone metastatic tumor growth by a tibial tumorigenesis assay. Bio Protoc. 11, e4231 (2021).","journal-title":"Bio Protoc."},{"key":"2703_CR99","unstructured":"Chang, J. & Erler, J. T. in Tumor Microenvironment. (eds C. Koumenis, L. M. Coussens, A. Giaccia, & E. Hammond) 245-251 (Springer International Publishing)."},{"key":"2703_CR100","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/0022-5193(68)90069-6","volume":"21","author":"JM Zimmerman","year":"1968","unstructured":"Zimmerman, J. M., Eliezer, N. & Simha, R. The characterization of amino acid sequences in proteins by statistical methods. J. Theor. Biol. 21, 170\u2013201 (1968).","journal-title":"J. Theor. Biol."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02703-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02703-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02703-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T19:01:20Z","timestamp":1775588480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02703-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2703"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02703-7","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}